Lexicon Pharmaceuticals

LXRX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 26 days ago

Total Revenue

$5.49M

Previous year: $26.6M

-79.3%

EPS

-$0.04

Previous year: -$0.09

-55.6%

R&D Expenses

$11.3M

Previous year: $26.7M

-57.6%

SG&A Expenses

$8.76M

Previous year: $32.3M

-72.9%

Total Operating Expenses

$20.3M

Previous year: $59.3M

Loading...

Lexicon Pharmaceuticals

Unlock previous datapoints

Upgrade

Lexicon Pharmaceuticals

Unlock previous datapoints

Upgrade

Lexicon Pharmaceuticals Revenue by Segment

Revenue by Segment

Net Product Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Licensing Revenue

CapyFin.com

Royalties and Other Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$699M

P/E Ratio

-3.95

Sector

N/A

Industry

N/A

52-Week High

$1.76

52-Week Low

$0.398

R&D Expenses

$11.3M

SG&A Expenses

$8.76M

Total Operating Expenses

$20.3M

Weighted Avg Shares

363.43M

Products

Get in Touch

Resources

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Revenue by Segment

Revenue by Segment

Net Product Revenue

Licensing Revenue

Royalties and Other Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics